NASCENT BIOTECH INC (NBIO) earnings
Quarterly and annual NBIO reports and results, each read against the price at its own news timestamp. Back to the NBIO overview →
5 measured NBIO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-Q Nascent Biotech Inc. For: Sep 30 | SEC filing · Form NT | — | +0.00% | |
| Form 10-Q Nascent Biotech Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-K Nascent Biotech Inc. For: Mar 31 | SEC filing · Form 10-K | +0.00% | -8.50% | |
| Form 10-Q Nascent Biotech Inc. For: Dec 31 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q Nascent Biotech Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +5.26% |
Keep exploring
More NBIO: analyst actions → · SEC filings → · NBIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| FIRST CHOICE HLTHCRE INC (FCHS) | 34 | 0.00% | 7% |
| POSITRON CORP (POSC) | 34 | 0.00% | 35% |
| NON-INVASIVE MONITORG SYS (NIMU) | 33 | 0.00% | 5% |
| PACIFIC HLTH CRE ORGZ INC (PFHO) | 33 | 0.00% | 29% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.